Zoom link is included in confirmation email after registering and will also be sent to attendees a few days prior to the event.
Description: In the rapidly evolving landscape of neurotechnology, there is much to explore not only in its astounding developments but also the pivotal steps required to de-risk innovations in this dynamic field. From combatting mental health challenges, to preventing aging and neurodegeneration in patients, what does it take to build a neurotech startup and guarantee success in this field?
Learn from rising entrepreneurs in this space about funding and regulatory strategies they've pursued, as well as how they've surpassed challenges in de-risking and obtaining data for their neurotech in a relatively new and evolving environment ripe with ethical considerations.
Topics of discussion:
· Overcoming challenges in de-risking neurotech innovations early on
· Navigating the regulatory landscape for neurotech including ethical considerations
· Successful examples of translation of neurotech innovations
· Funding strategies for neurotech startups
· Future trends in neurotech for combatting mental health, aging, preventing neurodegenerative disease progression, and more
· Strategic partnerships in this area
Panelists:
- Susan Pannullo, MD - Professor of Clinical Neurological Surgery, Weill Cornell Medicine, Adjunct Professor of Biomedical Engineering (Moderator)
- Benjamin Rapoport, MD, PhD - Co-Founder, CSO, Precision Neuroscience Neurosurgeon, Mount Sinai (Panelist)
- Sudhin Shah, MS, PhD - CSO, Alert Neurotechnologies, Assistant Professor, Neuroscience, Radiology (Panelist)
- Katya Sverdlov, CFA, Esq - Co-Founder, CEO, JelikaLite Corp. (Panelist)
